Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab

Clinical trial NCT01471691 · COMPLETED

Trial details

NCT number: NCT01471691
Sponsor: Hanscom, Thomas, M.D.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Branch Retinal Vein Occlusion Central Retinal Vein Occlusion Macular Edema

Start date: 2011-11-01
Primary completion: 2014-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.